These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12666098)

  • 21. COX-2 and neurodegeneration in Parkinson's disease.
    Teismann P; Vila M; Choi DK; Tieu K; Wu DC; Jackson-Lewis V; Przedborski S
    Ann N Y Acad Sci; 2003 Jun; 991():272-7. PubMed ID: 12846993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of cell death in experimental models of Parkinson's disease.
    Hirsch EC; Hunot S; Hartmann A
    Funct Neurol; 2000; 15(4):229-37. PubMed ID: 11213526
    [No Abstract]   [Full Text] [Related]  

  • 23. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
    Sidhu A; Wersinger C; Vernier P
    FEBS Lett; 2004 May; 565(1-3):1-5. PubMed ID: 15135042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway.
    Marchetti B; Serra PA; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Cioni S; Gennuso F; Rocchitta G; Desole MS; Mazzarino MC; Miele E; Morale MC
    Ann N Y Acad Sci; 2005 Dec; 1057():296-318. PubMed ID: 16399902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Parkinson disease: mechanisms of cell death].
    Michel PP; Hirsch EC; Agid Y
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S24-32. PubMed ID: 12690661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects.
    Lu L; Neff F; Fischer DA; Henze C; Hirsch EC; Oertel WH; Schlegel J; Hartmann A
    Neurobiol Dis; 2006 Aug; 23(2):409-21. PubMed ID: 16753304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal dopaminergic neurons are lost with Parkinson's disease progression.
    Porritt MJ; Kingsbury AE; Hughes AJ; Howells DW
    Mov Disord; 2006 Dec; 21(12):2208-11. PubMed ID: 17029264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease?
    Le Pen G; Sonnier L; Hartmann A; Bizot JC; Trovero F; Krebs MO; Prochiantz A
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S107-11. PubMed ID: 18585951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains.
    Smith Y; Villalba R
    Mov Disord; 2008; 23 Suppl 3():S534-47. PubMed ID: 18781680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanism of cell death in neurodegenerative disorders: apropos of Parkinson disease].
    Agid Y
    C R Seances Soc Biol Fil; 1993; 187(1):37-46. PubMed ID: 8242421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?
    Damier P; Kastner A; Agid Y; Hirsch EC
    Neurology; 1996 May; 46(5):1262-9. PubMed ID: 8628464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration.
    Teismann P; Tieu K; Choi DK; Wu DC; Naini A; Hunot S; Vila M; Jackson-Lewis V; Przedborski S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5473-8. PubMed ID: 12702778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effects of dopamine and Zn2+ on the induction of PC12 cell death and dopamine depletion in the striatum: possible implication in the pathogenesis of Parkinson's disease.
    Lo HS; Chiang HC; Lin AM; Chiang HY; Chu YC; Kao LS
    Neurobiol Dis; 2004 Oct; 17(1):54-61. PubMed ID: 15350965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroinflammation in Parkinson's disease.
    Hirsch EC; Vyas S; Hunot S
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S210-2. PubMed ID: 22166438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide.
    Członkowska A; Kurkowska-Jastrzebska I; Członkowski A; Peter D; Stefano GB
    Med Sci Monit; 2002 Aug; 8(8):RA165-77. PubMed ID: 12165754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
    Mogi M; Kondo T; Mizuno Y; Nagatsu T
    Neurosci Lett; 2007 Feb; 414(1):94-7. PubMed ID: 17196747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
    Iravani MM; Leung CC; Sadeghian M; Haddon CO; Rose S; Jenner P
    Eur J Neurosci; 2005 Jul; 22(2):317-30. PubMed ID: 16045485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.